Therefore, we speculated that LTA4H not only participates in the regulation of cancer through the inflammatory mediator pathway, but also influences the production of different subtypes of proteins by binding the RNA of target genes to regulate the alternative splicing process, thus regulating the proliferation, migration, and invasion of LSCC. The gene discussed is LTA4H; the disease is cancer.